• Birinapant: A Causal Apoptosis Map in CRC

  2026-09-29

  Birinapant (TL32711) can help researchers separate p53-dependent treatment priming from downstream IAP-controlled apoptosis in colorectal cancer models. This article presents a mechanistic assay framework that connects the MDM1–YBX1–TP53 axis with caspase-8 signaling, TNF responses, and TRAIL potency enhancement.

• ECL Chemiluminescent Substrate Detection Kit

  2026-09-29

  The ECL Chemiluminescent Substrate Detection Kit (Enhanced) supports sensitive HRP-based western blot chemiluminescence detection when low-abundance proteins require signal amplification and controlled background. It is intended for direct or indirect HRP-labeled antibody assays and should not be treated as a universal substrate for non-HRP detection systems or as independent validation of assay performance in other formats.

• BCECF for Extracellular pH in Pain Research

  2026-09-28

  BCECF is a ratiometric fluorescent pH probe for quantifying extracellular acidity without confusing pH signals with intracellular dye loading. This article develops an assay framework that connects BCECF measurements to macrophage efferocytosis, neuroinflammation, and the mechanistic findings of recent neuropathic pain research.

• HSP90 Inhibition Rewires Lung Adenocarcinoma Proteomes

  2026-09-28

  This study used two-dimensional electrophoresis coupled with mass spectrometry to map protein-profile changes after pharmacological HSP90 inhibition in lung adenocarcinoma cell lines. It identified 254 differentially expressed proteins and nominated eIF3i and citrate synthase as candidate response biomarkers, while linking treatment responses to apoptosis, serine-glycine biosynthesis, and the tricarboxylic acid cycle.

• Filipin III for Membrane Cholesterol Detection

  2026-09-27

  Filipin III provides an endpoint readout of accessible membrane cholesterol, making it a useful complement to studies of macrophage lipid storage and fibrosis. This workflow explains how to pair membrane cholesterol visualization with orthogonal measurements—without mistaking a cholesterol-binding probe for a direct assay of cholesteryl esters or lipophagy.

• H2S Persulfidation Sensitizes NSCLC to Ferroptosis

  2026-09-26

  Zheng and colleagues report that hydrogen sulfide promotes ferroptosis in non-small cell lung cancer cells, particularly when cystine is limited, by persulfidating and inhibiting S-adenosyl homocysteine hydrolase. The resulting reduction in homocysteine, cysteine, and glutathione points to a metabolic route for increasing tumor-cell vulnerability, although the findings do not by themselves establish a clinical treatment strategy.

• Lisinopril Dihydrate: Selectivity for Better Assays

  2026-09-25

  Lisinopril dihydrate is an ACE inhibitor used to investigate renin–angiotensin signaling in cardiovascular and renal models. This guide connects its pathway effects with an important selectivity study to help researchers distinguish ACE target engagement from broader peptidase activity.

• Filipin III for Membrane Cholesterol Detection

  2026-09-25

  Filipin III is a polyene macrolide antibiotic used to visualize cholesterol distribution in membranes through cholesterol binding, fluorescence changes, and ultrastructural effects. This guide explains what the probe can establish, how to handle it, and why it is not a direct readout of oxysterols or cholesterol concentration.

• Huangqin Decoction and the Microbiota–AhR Repair Axis

  2026-09-24

  Li et al. identify a microbiota–tryptophan metabolite–AhR pathway associated with intestinal stem-cell differentiation and mucosal repair in a mouse model of ulcerative colitis. The findings connect changes in microbial metabolites to AhR activity and epithelial-lineage markers, while antibiotic and AhR-inhibitor interventions provide evidence that both microbiota and receptor signaling contribute to the observed effects.

• QNZ (EVP4593): NF-κB Workflow & Applications

  2026-09-24

  Build a practical NF-κB workflow around QNZ (EVP4593), a nanomolar inhibitor with reported effects in stimulated Jurkat cells and models relevant to inflammation and Huntington’s disease research. This guide pairs dose-response testing with reporter, cytokine, and viability readouts—and flags where the evidence does not support extrapolation.

• SkQ1 and Mitochondrial Signalling in Ovarian Cancer Atrophy

  2026-09-23

  In an orthotopic ovarian cancer model, SkQ1 reduced late-stage mitochondrial hydrogen peroxide emission and caspase activity but did not prevent skeletal muscle fibre atrophy. The results challenge a simple causal link between these mitochondrial signals and atrophy, while showing why disease stage, muscle-fibre type, and direct measures of tissue outcomes matter when interpreting cell-death markers.

• Morin C5297: Reliable Cell Assay Workflows

  2026-09-23

  This scenario-based guide shows how Morin (SKU C5297) can be integrated into viability, mitochondrial, and cytotoxicity workflows while controlling solvent, optical, and formulation variables. It connects product specifications with recent podocyte-energy research and practical vendor-selection criteria.

• Mitoxantrone Targets the ERα DBD–LBD Interface

  2026-09-22

  The reference study identifies mitoxantrone as a ligand for an underexplored interface between the estrogen receptor α DNA-binding and ligand-binding domains. Its binding promotes receptor relocalization and proteasomal degradation, suppressing wild-type and endocrine-resistant ERα signaling through a mechanism distinct from conventional hormone-pocket antagonism.

• BV6 as an IAP Antagonist for Cell-Death Mapping

  2026-09-22

  Explore how BV6, an IAP antagonist and Smac mimetic, can separate apoptosis sensitization from necroptosis competence in cancer research. This article connects BV6 mechanism, formulation, and assay design with insights from a 2025 Orientia–RIPK3 study.

• PYR-41: Testing E1 Control of IRF7 Degradation

  2026-09-21

  PYR-41, an inhibitor of Ubiquitin-Activating Enzyme E1, offers a mechanistically focused way to test how ubiquitination influences IRF7 stability and antiviral signaling. This article translates recent IBDV–VP3 findings into practical assay logic while clearly separating established evidence from research hypotheses.

8586 records 1/573 page Next 12345 下5页 Last page